ALIROCUMAB
UNII PP0SHH6V16

Substance Identification & Data

This profile provides standardized clinical and technical data for Alirocumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PP0SHH6V16.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1245916-14-6 and the RxNorm Concept ID (RxCUI) 1659152. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

PP0SHH6V16

CAS Registry Number

1245916-14-6

RxNorm Concept ID

1659152

Detailed Substance Profile

Preferred Name

ALIROCUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

PP0SHH6V16

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C174849

National Cancer Institute reference terminology for clinical and research data.

INN ID

9620

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

YY-133

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Alirocumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ALIROCUMAB

Common Names & Synonyms

ALIROCUMAB [INN]

ALIROCUMAB [JAN]

ALIROCUMAB [MI]

ALIROCUMAB [PURPLE BOOK CDER]

ALIROCUMAB [USAN]

ALIROCUMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN NEURAL APOPTOSIS-REGULATED PROTEINASE 1) (HUMAN REGN727 HEAVY CHAIN), DISULFIDE WITH HUMAN REGN727 .KAPPA.-CHAIN, DIMER